| DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? JA Roberts, SK Paul, M Akova, M Bassetti, JJ De Waele, G Dimopoulos, ... Clinical infectious diseases 58 (8), 1072-1083, 2014 | 1063 | 2014 |
| A multicenter randomized trial of continuous versus intermittent β-lactam infusion in severe sepsis JM Dulhunty, JA Roberts, JS Davis, SAR Webb, R Bellomo, C Gomersall, ... American journal of respiratory and critical care medicine 192 (11), 1298-1305, 2015 | 253 | 2015 |
| Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients JJ De Waele, J Lipman, M Akova, M Bassetti, G Dimopoulos, M Kaukonen, ... Intensive care medicine 40, 1340-1351, 2014 | 189 | 2014 |
| Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An … MH Abdul-Aziz, J Lipman, M Akova, M Bassetti, JJ De Waele, ... Journal of Antimicrobial Chemotherapy 71 (1), 196-207, 2016 | 167 | 2016 |
| Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: data from multinational Defining Antibiotic Levels in … MG Sinnollareddy, JA Roberts, J Lipman, M Akova, M Bassetti, ... Critical care 19, 1-7, 2015 | 137 | 2015 |
| Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study S Blot, D Koulenti, M Akova, M Bassetti, JJ De Waele, G Dimopoulos, ... Critical Care 18, 1-12, 2014 | 133 | 2014 |
| The effect of renal replacement therapy and antibiotic dose on antibiotic concentrations in critically ill patients: data from the multinational sampling antibiotics in renal … JA Roberts, GM Joynt, A Lee, G Choi, R Bellomo, S Kanji, MY Mudaliar, ... Clinical Infectious Diseases 72 (8), 1369-1378, 2021 | 103 | 2021 |
| Association between augmented renal clearance and clinical outcomes in patients receiving β-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort … AA Udy, JM Dulhunty, JA Roberts, JS Davis, SAR Webb, R Bellomo, ... International journal of antimicrobial agents 49 (5), 624-630, 2017 | 97 | 2017 |
| Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds AA Udy, P Jarrett, J Stuart, M Lassig-Smith, T Starr, R Dunlop, SC Wallis, ... Critical care 18, 1-9, 2014 | 77 | 2014 |
| Population pharmacokinetics of piperacillin in nonobese, obese, and morbidly obese critically ill patients AS Alobaid, SC Wallis, P Jarrett, T Starr, J Stuart, M Lassig-Smith, ... Antimicrobial agents and chemotherapy 61 (3), 10.1128/aac. 01276-16, 2017 | 72 | 2017 |
| DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically … JA Roberts, JJ De Waele, G Dimopoulos, D Koulenti, C Martin, ... BMC infectious diseases 12, 1-7, 2012 | 69 | 2012 |
| Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: lessons from the DALI Study JA Roberts, V Stove, JJ De Waele, B Sipinkoski, B McWhinney, ... International journal of antimicrobial agents 43 (5), 423-430, 2014 | 66 | 2014 |
| Augmented renal clearance in traumatic brain injury: a single-center observational study of atrial natriuretic peptide, cardiac output, and creatinine clearance AA Udy, P Jarrett, M Lassig-Smith, J Stuart, T Starr, R Dunlop, R Deans, ... Journal of neurotrauma 34 (1), 137-144, 2017 | 62 | 2017 |
| A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III J Lipman, SJ Brett, JJ De Waele, MO Cotta, JS Davis, S Finfer, P Glass, ... Critical Care and Resuscitation 21 (1), 63-68, 2019 | 61 | 2019 |
| Effect of obesity on the population pharmacokinetics of fluconazole in critically ill patients AS Alobaid, SC Wallis, P Jarrett, T Starr, J Stuart, M Lassig-Smith, ... Antimicrobial agents and chemotherapy 60 (11), 6550-6557, 2016 | 55 | 2016 |
| A comparison of CKD-EPI estimated glomerular filtration rate and measured creatinine clearance in recently admitted critically ill patients with normal plasma creatinine … AA Udy, FJA Morton, S Nguyen-Pham, P Jarrett, M Lassig-Smith, J Stuart, ... BMC nephrology 14, 1-7, 2013 | 54 | 2013 |
| Effect of obesity on the population pharmacokinetics of meropenem in critically ill patients AS Alobaid, SC Wallis, P Jarrett, T Starr, J Stuart, M Lassig-Smith, ... Antimicrobial agents and chemotherapy 60 (8), 4577-4584, 2016 | 50 | 2016 |
| Glucocorticoid sensitivity is highly variable in critically ill patients with septic shock and is associated with disease severity J Cohen, CJ Pretorius, JPJ Ungerer, J Cardinal, A Blumenthal, J Presneill, ... Critical Care Medicine 44 (6), 1034-1041, 2016 | 47 | 2016 |
| Population pharmacokinetics of unbound ceftolozane and tazobactam in critically ill patients without renal dysfunction FB Sime, M Lassig-Smith, T Starr, J Stuart, S Pandey, SL Parker, ... Antimicrobial Agents and Chemotherapy 63 (10), 10.1128/aac. 01265-19, 2019 | 41 | 2019 |
| Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration JA Roberts, AA Udy, JB Bulitta, J Stuart, P Jarrett, T Starr, M Lassig-Smith, ... Journal of Antimicrobial Chemotherapy 69 (9), 2508-2516, 2014 | 36 | 2014 |
